Criteria
Leader criteria
Sector
Communication Services
80
Consumer Discretionary
292
Consumer Staples
106
Energy
122
Financials
467
Health Care
446
Industrials
477
Information Technology
431
Materials
223
Real Estate
119
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCSG | Healthcare Services Group Inc | Health Care | $24.52 | down 3.1% | up 19.9% | up 33.9% | 3.2% | 73 | 8/8 | $1.7B | 28.9× | 0.56 | up 12% | 3.3× | — | down 39% | 8/9 | Low | |
| HELP | Helus Pharma Inc. | Health Care | $10.60 | up 4.0% | down 13.8% | up 47.6% | 8.1% | 94 | 7/8 | — | — | — | — | — | — | — | — | Unknown | |
| HIMS | Hims & Hers Health, Inc. | Health Care | $27.68 | down 0.1% | down 7.1% | down 37.2% | 6.5% | 24 | 3/8 | — | — | — | up 25% | — | — | down 325% | — | Moderate | |
| HLF | Herbalife Ltd. | Health Care | $13.05 | down 2.5% | up 7.6% | up 68.4% | 3.9% | 52 | 2/8 | $1.3B | 5.9× | — | — | — | — | down 153% | 5/9 | Elevated | |
| HRMY | Harmony Biosciences Holdings, Inc. | Health Care | $38.76 | up 7.3% | down 1.3% | up 34.1% | 3.9% | 71 | 7/8 | $2.2B | 14.1× | 1.80 | up 21% | 2.6× | 0.17 | up 89% | 5/9 | Low | |
| HROW | Harrow, Inc. | Health Care | $28.24 | down 0.7% | down 8.3% | down 24.8% | 4.8% | 9 | 0/8 | $1.1B | — | — | down 8% | 20.0× | 4.77 | down 460% | 6/9 | Moderate | |
| HSIC | Henry Schein Inc | Health Care | $84.88 | down 0.1% | up 1.1% | up 34.9% | 2.2% | 66 | 6/8 | $9.8B | 23.5× | 2.23 | up 13% | 3.0× | 0.72 | up 17% | 6/9 | Low | |
| HTFL | Heartflow, Inc. | Health Care | $59.05 | up 4.1% | up 18.7% | up 61.5% | 4.9% | 98 | 8/8 | $5.0B | — | — | down 39% | 16.7× | — | — | — | Low | |
| HUM | Humana Inc | Health Care | $414.50 | down 1.6% | up 8.9% | up 46.7% | 3.5% | 93 | 8/8 | $82.4B | 69.3× | — | up 7% | 4.7× | 0.70 | — | — | Low | |
| IAM | Iambic Therapeutics, Inc. | Health Care | $13.43 | down 5.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | Unknown | |
| IART | Integra Lifesciences Holdings Corp | Health Care | $12.75 | up 7.1% | down 21.7% | up 8.0% | 5.6% | 29 | 3/8 | $1.2B | — | — | down 40% | 1.1× | 0.70 | — | 4/9 | Elevated | |
| IBRX | Immunitybio, Inc. | Health Care | $8.29 | up 0.9% | down 12.2% | up 251.3% | 8.0% | 95 | 6/8 | $8.4B | — | — | — | — | — | — | 4/9 | Elevated | |
| ICLR | Icon Plc | Health Care | $211.36 | up 14.1% | up 24.3% | up 27.8% | 4.5% | 90 | 7/8 | $16.2B | 70.6× | — | up 2% | 1.8× | 0.31 | — | — | Moderate | |
| ICUI | Icu Medical Inc/De | Health Care | $163.78 | down 1.7% | up 2.0% | up 36.8% | 3.1% | 71 | 7/8 | $4.0B | 5523.8× | — | 0% | 1.9× | 0.60 | down 47% | 6/9 | Moderate | |
| IDXX | Idexx Laboratories Inc /De | Health Care | $551.21 | down 1.6% | up 5.6% | down 12.3% | 2.8% | 30 | 1/8 | $43.9B | 41.5× | 1.84 | up 66% | 27.4× | 0.23 | up 18% | 8/9 | Low | |
| IDYA | Ideaya Biosciences, Inc. | Health Care | $31.96 | down 7.9% | down 16.8% | up 1.1% | 4.7% | 40 | 3/8 | $2.8B | — | — | down 11% | 2.7× | — | — | — | Low | |
| ILMN | Illumina, Inc. | Health Care | $235.99 | down 12.4% | down 13.8% | up 138.3% | 7.2% | 95 | 7/8 | $36.1B | 42.5× | — | up 33% | 13.3× | 0.55 | up 47% | 8/9 | Low | |
| IMMX | Immix Biopharma, Inc. | Health Care | $7.68 | down 5.8% | down 26.2% | up 109.3% | 7.9% | 77 | 5/8 | $406.7M | — | — | down 55% | 4.3× | — | — | — | Unknown | |
| IMNM | Immunome Inc. | Health Care | $18.21 | up 1.2% | down 15.3% | up 14.0% | 5.5% | 21 | 0/8 | $2.1B | — | — | down 52% | 3.2× | — | — | — | Low | |
| IMTX | Immatics N.V. | Health Care | $7.20 | down 1.5% | down 18.0% | down 30.9% | 6.1% | 11 | 0/8 | — | — | — | — | — | — | — | — | Unknown | |
| IMVT | Immunovant, Inc. | Health Care | $29.17 | up 2.7% | down 13.6% | up 17.5% | 4.1% | 45 | 4/8 | $5.9B | — | — | down 65% | 7.0× | — | — | — | Unknown | |
| INBX | Inhibrx Biosciences, Inc. | Health Care | $71.78 | down 23.1% | down 28.3% | down 8.6% | 10.5% | 18 | 3/8 | $1.0B | — | — | down 198% | 130.9× | 12.58 | — | — | Elevated | |
| INCY | Incyte Corp | Health Care | $120.39 | up 4.0% | down 0.8% | up 30.0% | 3.1% | 72 | 7/8 | $23.9B | 18.6× | 0.00 | up 30% | 4.6× | — | down 283% | 8/9 | Low | |
| INDP | Indaptus Therapeutics, Inc. | Health Care | $3.09 | down 2.2% | up 34.3% | — | 11.2% | — | — | $6.7M | — | — | down 588% | 2.1× | — | — | — | Unknown | |
| INDV | Indivior Pharmaceuticals, Inc. | Health Care | $35.37 | up 2.6% | down 1.3% | up 21.4% | 3.5% | 52 | 3/8 | $4.4B | 21.1× | 0.01 | — | — | — | up 245% | 4/9 | Low |